Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Bruker (BRKRP) over the last 17 years, with Q3 2025 value amounting to $604.0 million.

  • Bruker's Other Accumulated Expenses rose 149.55% to $604.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $604.0 million, marking a year-over-year increase of 149.55%. This contributed to the annual value of $576.5 million for FY2024, which is 2055.63% up from last year.
  • Per Bruker's latest filing, its Other Accumulated Expenses stood at $604.0 million for Q3 2025, which was up 149.55% from $570.6 million recorded in Q2 2025.
  • Over the past 5 years, Bruker's Other Accumulated Expenses peaked at $604.0 million during Q3 2025, and registered a low of $334.4 million during Q1 2023.
  • For the 5-year period, Bruker's Other Accumulated Expenses averaged around $489.9 million, with its median value being $493.6 million (2022).
  • In the last 5 years, Bruker's Other Accumulated Expenses tumbled by 3225.28% in 2023 and then soared by 6169.28% in 2024.
  • Quarter analysis of 5 years shows Bruker's Other Accumulated Expenses stood at $481.2 million in 2021, then decreased by 27.89% to $347.0 million in 2022, then surged by 37.81% to $478.2 million in 2023, then grew by 20.56% to $576.5 million in 2024, then increased by 4.77% to $604.0 million in 2025.
  • Its Other Accumulated Expenses stands at $604.0 million for Q3 2025, versus $570.6 million for Q2 2025 and $592.0 million for Q1 2025.